Revathi Kollipara

[Revathi Kollipara @rkollipa]

So grateful to have the best mentor! #ASCO23

[Alan Tan @alantanmd]

Very proud of @rkollipa as presenting author of our ctDNA MRD poster in stage II/III #Melanoma @RushMedical @RushHemOnc @NateraGenetics

[Revathi Kollipara @rkollipa]

@EricaParkMD @andrewsris1 So proud! Congrats @andrewsris1!

[Alan Tan @alantanmd]

Poster K10: In advanced stage #RCC: detectable #ctDNA showed a 90.9% concordance with progression (20/22); undetectable ctDNA showed an 83.3% concordance. Non-clear cell sheds significantly more. Proud of RISING STAR @rkollipa @arnabguonc @RushHemOnc @RushMedical #GU23

[RUSH Heme/Onc @RushHemOnc]

Team Rush at the Leukemia & Lymphoma Society’s Light the Night! Great night honoring and supporting patients with blood cancers. @ Soldier Field https://t.co/PlejGgTScM

[Alan Tan @alantanmd]

Very relevant discussion which just had this morning with 79 year old with T3a RCC as he goes home to ponder our discussion. @rkollipa @RushHemOnc

[RUSH Heme/Onc @RushHemOnc]

Great multi disciplinary case-based presentation at today’s medical grand rounds of a patient with HIV+/HHV8+ multicentric Castleman disease who presented with fevers and AMS, thrombocytopenia, diffuse LAD, and ARF. Amazing recovery of plt count with weekly rituximab.

[Alan Tan @alantanmd]

Another triple therapy to choose from in mHSPC! PEACE-1 or ARASENS @rkollipa @AmiDave20 @TahaAlrifai1 How will you choose? @RushHemOnc

[Alan Tan @alantanmd]

After a long queue after FDA approval, Our first patient on Lu177 PSMA 617 for mCRPC @RushCancer just sent me this nice message after first dose. Clearly a game changer. @revkolli @RushHemOnc

[RUSH Heme/Onc @RushHemOnc]

Rush fellows at #ASCO22 post plenary session. So much exciting data!

[RUSH Heme/Onc @RushHemOnc]

Great advice on recommending vaccination for our immunocompromised patients despite them not being able to amount a great immune response. “Some degree of immunity is better than no degree.” Thank you Dr. Fauci for your leadership and inspiring all of us. @DrAnthonyF #ASH20

[Melissa @mlarsonmd]

First day of Heme Onc fellowship interviews today. Excited to meet our potential future fellows! @RushHemOnc @RushCancer

[Rush Cancer Center @RushCancer]

Over her lifetime, a woman in the United States has about a one in eight chance of developing breast cancer. Rush medical oncologist Ruta Rao, MD, shares five important facts that every woman needs to know. https://t.co/7rnggjtZYs

[RUSH Heme/Onc @RushHemOnc]

We are very excited to announce the Twitter account of the Hematology/Oncology fellowship program @RushCancer! We will be posting program highlights, events, tweetorials, and updates on our current and former fellows! @RushMedical #MedEd #Hematology #Oncology